Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
FOSLINANIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FOSLINANIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2X2DNM7NGX
Molecule Type:
Small molecule
Molecular Formula:
C16H13FNO6P
Molecular Weight:
365.25
AlogP:
2.81
PSA:
108.85
HBD:
3.0
HBA:
#RotB:
4.0
Source:
IDOXIFENE
(2)
Small molecule
Estrogen receptor modulator
Unknown
Investigational
Unknown
IDOXIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
456UXE9867
Molecule Type:
Small molecule
Molecular Formula:
C28H30INO
Molecular Weight:
523.46
AlogP:
7.13
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
8.0
Source:
IOPOFOSINE I 131
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IOPOFOSINE I 131
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALABOSTAT MESYLATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TALABOSTAT MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
V8ZG4Y1B51
Molecule Type:
Small molecule
Molecular Formula:
C10H23BN2O6S
Molecular Weight:
310.18
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DWP05195
(2)
Small molecule
Vanilloid receptor antagonist
Unknown
Investigational
Unknown
DWP05195
×
Maximum Phase:
2
First Approval:
None
UNII:
7AH7G4DT2X
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELTA 8-TETRAHYDROCANNOBINOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DELTA 8-TETRAHYDROCANNOBINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
B49D0HH807
Molecule Type:
Small molecule
Molecular Formula:
C21H30O2
Molecular Weight:
314.47
AlogP:
5.74
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
(-)-EPICATECHIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
(-)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
34PHS7TU43
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
PEGAMOTECAN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PEGAMOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
ZY7ZTE7LFH
Molecule Type:
Small molecule
Molecular Formula:
C52H48N6O14
Molecular Weight:
980.98
AlogP:
3.32
PSA:
251.64
HBD:
2.0
HBA:
#RotB:
15.0
Source:
NAXIFYLLINE
(2)
Small molecule
Adenosine A1 receptor antagonist
Unknown
Investigational
Unknown
NAXIFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
B3G45WC37L
Molecule Type:
Small molecule
Molecular Formula:
C18H24N4O3
Molecular Weight:
344.42
AlogP:
1.6
PSA:
85.21
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CIFORADENANT
(2)
Small molecule
Adenosine A2a receptor antagonist
Unknown
Investigational
Unknown
CIFORADENANT
×
Maximum Phase:
2
First Approval:
None
UNII:
8KFO2187CP
Molecule Type:
Small molecule
Molecular Formula:
C20H21N7O3
Molecular Weight:
407.43
AlogP:
2.12
PSA:
127.0
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PEGCANTRATINIB
(2)
Small molecule
Nerve growth factor receptor Trk-A inhibitor
Unknown
Investigational
Unknown
PEGCANTRATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
VG44NU1168
Molecule Type:
Small molecule
Molecular Formula:
C30H24N4O6
Molecular Weight:
536.54
AlogP:
4.12
PSA:
104.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
.ALPHA.-R-LIPOIC ACID CHOLINE ESTER
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
.ALPHA.-R-LIPOIC ACID CHOLINE ESTER
×
Maximum Phase:
2
First Approval:
None
UNII:
H3PX4O36U1
Molecule Type:
Small molecule
Molecular Formula:
C13H26NO2S2+
Molecular Weight:
292.49
AlogP:
2.95
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
8.0
Source:
XL-820
(2)
Small molecule
Platelet-derived growth factor receptor inhibitor
Unknown
Investigational
Unknown
XL-820
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RIMACALIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RIMACALIB
×
Maximum Phase:
2
First Approval:
None
UNII:
BZ76J3N815
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN4O2
Molecular Weight:
394.45
AlogP:
4.31
PSA:
74.38
HBD:
2.0
HBA:
#RotB:
4.0
Source:
VEDROPREVIR
(2)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Investigational
Unknown
VEDROPREVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
KGD958X2B9
Molecule Type:
Small molecule
Molecular Formula:
C45H60ClN7O9S
Molecular Weight:
910.53
AlogP:
6.2
PSA:
193.78
HBD:
4.0
HBA:
#RotB:
16.0
Source:
AMDOXOVIR
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
AMDOXOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
54I81H0M9C
Molecule Type:
Small molecule
Molecular Formula:
C9H12N6O3
Molecular Weight:
252.23
AlogP:
-1.15
PSA:
134.33
HBD:
3.0
HBA:
#RotB:
2.0
Source:
OLINCIGUAT
(2)
Small molecule
Soluble guanylate cyclase positive allosteric modulator
Unknown
Investigational
Unknown
OLINCIGUAT
×
Maximum Phase:
2
First Approval:
None
UNII:
PD5F4ZXD21
Molecule Type:
Small molecule
Molecular Formula:
C21H16F5N7O3
Molecular Weight:
509.4
AlogP:
2.51
PSA:
144.98
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ZD-6126
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ZD-6126
×
Maximum Phase:
2
First Approval:
None
UNII:
GBO3S6M9W7
Molecule Type:
Small molecule
Molecular Formula:
C20H24NO8P
Molecular Weight:
437.39
AlogP:
2.97
PSA:
123.55
HBD:
3.0
HBA:
#RotB:
6.0
Source:
GOZETOTIDE ALF-18
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GOZETOTIDE ALF-18
×
Maximum Phase:
2
First Approval:
None
UNII:
J1W7SQ7GC4
Molecule Type:
Small molecule
Molecular Formula:
C44H60AlFN6O17
Molecular Weight:
989.97
AlogP:
1.55
PSA:
370.07
HBD:
12.0
HBA:
#RotB:
35.0
Source:
PENTALYTE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PENTALYTE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
H3Cl2K2MgNa3O12P2S
Molecular Weight:
531.4
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PSILOCIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PSILOCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALT-2074
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALT-2074
×
Maximum Phase:
2
First Approval:
None
UNII:
634U7OUR4R
Molecule Type:
Small molecule
Molecular Formula:
C10H13NSe
Molecular Weight:
226.18
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GELDANAMYCIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GELDANAMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Z3K3VJ16KU
Molecule Type:
Small molecule
Molecular Formula:
C29H40N2O9
Molecular Weight:
560.64
AlogP:
2.41
PSA:
163.48
HBD:
3.0
HBA:
#RotB:
4.0
Source:
UPROSERTIB
(2)
Small molecule
Serine/threonine-protein kinase AKT inhibitor
Unknown
Investigational
Unknown
UPROSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
ZXM835LQ5E
Molecule Type:
Small molecule
Molecular Formula:
C18H16Cl2F2N4O2
Molecular Weight:
429.25
AlogP:
3.56
PSA:
86.08
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ILEPATRIL
(2)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Investigational
Unknown
ILEPATRIL
×
Maximum Phase:
2
First Approval:
None
UNII:
5N1YAP5FCM
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O5S
Molecular Weight:
432.54
AlogP:
2.54
PSA:
103.78
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ONALESPIB
(2)
Small molecule
Heat shock protein HSP90 inhibitor
Unknown
Investigational
Unknown
ONALESPIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Q7Y33N57ZZ
Molecule Type:
Small molecule
Molecular Formula:
C24H31N3O3
Molecular Weight:
409.53
AlogP:
3.12
PSA:
67.25
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AVE8134
(2)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
Unknown
Investigational
Unknown
AVE8134
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAVOGLURANT
(2)
Small molecule
Metabotropic glutamate receptor 5 antagonist
Unknown
Investigational
Unknown
MAVOGLURANT
×
Maximum Phase:
2
First Approval:
None
UNII:
GT0I9SV4F6
Molecule Type:
Small molecule
Molecular Formula:
C19H23NO3
Molecular Weight:
313.4
AlogP:
2.72
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
0.0
Source:
FORETINIB
(2)
Small molecule
Hepatocyte growth factor receptor inhibitor
Unknown
Investigational
Unknown
FORETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
81FH7VK1C4
Molecule Type:
Small molecule
Molecular Formula:
C34H34F2N4O6
Molecular Weight:
632.66
AlogP:
5.77
PSA:
111.25
HBD:
2.0
HBA:
#RotB:
12.0
Source:
RAMATROBAN
(2)
Small molecule
G protein-coupled receptor 44 antagonist
Unknown
Investigational
Unknown
RAMATROBAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P1ALI72U6C
Molecule Type:
Small molecule
Molecular Formula:
C21H21FN2O4S
Molecular Weight:
416.47
AlogP:
3.09
PSA:
88.4
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SGS-742
(2)
Small molecule
GABA-B receptor antagonist
Unknown
Investigational
Unknown
SGS-742
×
Maximum Phase:
2
First Approval:
None
UNII:
GBZ5UC0RME
Molecule Type:
Small molecule
Molecular Formula:
C7H18NO2P
Molecular Weight:
179.2
AlogP:
1.41
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SEPANTRONIUM BROMIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SEPANTRONIUM BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
7H5Q4J1CM5
Molecule Type:
Small molecule
Molecular Formula:
C20H19BrN4O3
Molecular Weight:
443.3
AlogP:
1.34
PSA:
77.96
HBD:
0.0
HBA:
#RotB:
5.0
Source:
VIDUPIPRANT
(2)
Small molecule
G protein-coupled receptor 44 antagonist
Unknown
Investigational
Unknown
VIDUPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
61OTZ32XNC
Molecule Type:
Small molecule
Molecular Formula:
C28H27Cl2FN2O6S
Molecular Weight:
609.5
AlogP:
6.76
PSA:
121.8
HBD:
3.0
HBA:
#RotB:
9.0
Source:
ADELMIDROL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ADELMIDROL
×
Maximum Phase:
2
First Approval:
None
UNII:
1BUC3685QU
Molecule Type:
Small molecule
Molecular Formula:
C13H26N2O4
Molecular Weight:
274.36
AlogP:
-0.07
PSA:
98.66
HBD:
4.0
HBA:
#RotB:
12.0
Source:
INCYCLINIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
INCYCLINIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
21G64WZQ4I
Molecule Type:
Small molecule
Molecular Formula:
C19H17NO7
Molecular Weight:
371.35
AlogP:
0.58
PSA:
158.15
HBD:
5.0
HBA:
#RotB:
1.0
Source:
SITAFLOXACIN
(2)
Small molecule
Bacterial DNA gyrase inhibitor
Unknown
Investigational
Unknown
SITAFLOXACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9TD681796G
Molecule Type:
Small molecule
Molecular Formula:
C19H18ClF2N3O3
Molecular Weight:
409.82
AlogP:
2.7
PSA:
88.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
142
143
144
145
146
147
148
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA